CONDUCTING CLINICAL TRIALS
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| APICES | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen; |
| BAZICS | Wyeth (formerly American Home Products Corporation) | Five Giralda Farms Madison NJ 07940 | conducting clinical trials in the area of hormonal pharmaceutical preparations; |
| EMERGE | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | conducting clinical trials; |
| EPIC-SKIN | OncoBeta International GmbH | Baneggstrasse 57 Ravensburg 88214 Germany | Conducting clinical trials; conducting scientific studies; providing information on clinical and scientific studies; conducting scientific studies in the field of oncology; conducting surveys of patient data related to quality of life, treatment comfort and cosmetic results after medical treatments; scientific research for medical purposes; |
| ESTEEM | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; |
|
|
|||
| MARINA | Avidity Biosciences, Inc. | 10578 Science Drive, Suite 125 San Diego CA 92121 | conducting clinical trials in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; medical and scientific research, namely, conducting clinical trials for oligonucleotide-based therapeutics; |
| PACIFY | Landos Biopharma, Inc. | Unit 1071 4727 Valley View Boulevard Roanoke VA 24012 | Conducting clinical trials in the field of ulcerative colitis; |
| PALACE | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen; |
| PARACELSUS THERAPEUTICS | Paracelsus Therapeutics | 767 Fifth Avenue Suite 4600 New York NY 10153 | Conducting clinical trials in the areas of normal cognitive aging, Alzheimer's disease, and related dementias;Scientific research for medical purposes, namely drug discovery and drug development research in cognitive aging and Alzheimer's disease; |
| RACE | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | conducting clinical trials; conducting clinical trials on the safety and effectiveness of azacitidine in connection with Acute Myeloid Leukemia, Myelodysplastic Syndromes, Lymphoma, Multiple Myeloma, Leukemia, and Myelomonocytic Chronic Leukemia; |
| REACT | BRISTOL-MYERS SQUIBB COMPANY | 430 E. 29th Street, 14th Floor New York NY 10016 | Conducting clinical trials in the field of pharmaceutical preparations; |
| SPRINT | Celgene Corporation | 86 Morris Avenue Summit NJ 07901 | Conducting clinical trials in the field of hematology and oncology; |
Where the owner name is not linked, that owner no longer owns the brand |
|||
Technical Examples
- This patent describes a novel in vitro cell-based method for biological validation and pharmacological screening of drugs, new chemical entities (NCEs) and biologics, which is predictive of in vivo testing for efficacy and adverse events in patients, as occurs in clinical trials. The same method can be used to create an in vitro cell-based assay to identify the 'right marketed medication for the right patient' (personalized medicine), and to identify responders/non-responders in ongoing clinical trials with NCEs. In addition this approach can be used to identify new indications for existing medicines and new indications for NCEs that were unsuccessful in their intended uses.